Literature DB >> 18242183

The three-dimensional structure of the analgesic alpha-conotoxin, RgIA.

Richard J Clark1, Norelle L Daly, Reena Halai, Simon T Nevin, David J Adams, David J Craik.   

Abstract

The alpha-conotoxin RgIA is a selective antagonist of the alpha9alpha10 nicotinic acetylcholine receptor and has been shown to be a potent analgesic and reduces nerve injury associated inflammation. RgIA was chemically synthesized and found to fold into two disulfide isomers, globular and ribbon. The native globular isomer inhibited ACh-evoked currents reversibly in oocytes expressing rat alpha9alpha10 nAChRs but the ribbon isomer was inactive. We determined the three-dimensional structure of RgIA using NMR methods to assist in elucidating the molecular role of RgIA in analgesia and inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242183     DOI: 10.1016/j.febslet.2008.01.027

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 2.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

3.  γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.

Authors:  Hartmut Cuny; Andrew de Faoite; Thuan G Huynh; Takahiro Yasuda; Géza Berecki; David J Adams
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

4.  Chemical synthesis and characterization of two α4/7-conotoxins.

Authors:  Can Peng; Weihua Chen; Tanya Sanders; Geoffrey Chew; Jing Liu; Edward Hawrot; Chengwu Chi
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2010-08-27       Impact factor: 3.848

5.  Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.

Authors:  Reena Halai; Richard J Clark; Simon T Nevin; Jonas E Jensen; David J Adams; David J Craik
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

Review 6.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

Review 7.  Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

Authors:  J Michael McIntosh; Nathan Absalom; Mary Chebib; Ana Belén Elgoyhen; Michelle Vincler
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

8.  On-resin strategy to label α-conotoxins: Cy5-RgIA, a potent α9α10 nicotinic acetylcholine receptor imaging probe.

Authors:  Markus Muttenthaler; Simon T Nevin; Marco Inserra; Richard J Lewis; David J Adams; Paul Alewood
Journal:  Aust J Chem       Date:  2019-12-03       Impact factor: 1.321

Review 9.  Discovery, synthesis, and structure-activity relationships of conotoxins.

Authors:  Kalyana B Akondi; Markus Muttenthaler; Sébastien Dutertre; Quentin Kaas; David J Craik; Richard J Lewis; Paul F Alewood
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

10.  α -RgIB: A Novel Antagonist Peptide of Neuronal Acetylcholine Receptor Isolated from Conus regius Venom.

Authors:  Maria Cristina Vianna Braga; Arthur Andrade Nery; Henning Ulrich; Katsuhiro Konno; Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  Int J Pept       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.